Assetmark Inc. raised its holdings in shares of Monsanto Company (NYSE:MON) by 5,841.7% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 34,937 shares of the basic materials company’s stock after acquiring an additional 34,349 shares during the quarter. Assetmark Inc.’s holdings in Monsanto were worth $4,186,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the company. Vanguard Group Inc. grew its stake in shares of Monsanto by 2.6% during the 2nd quarter. Vanguard Group Inc. now owns 30,725,725 shares of the basic materials company’s stock worth $3,636,697,000 after acquiring an additional 784,418 shares in the last quarter. BlackRock Inc. grew its stake in shares of Monsanto by 6.5% during the 2nd quarter. BlackRock Inc. now owns 27,898,255 shares of the basic materials company’s stock worth $3,302,038,000 after acquiring an additional 1,705,439 shares in the last quarter. State Street Corp grew its stake in shares of Monsanto by 0.6% during the 2nd quarter. State Street Corp now owns 20,276,780 shares of the basic materials company’s stock worth $2,399,965,000 after acquiring an additional 122,814 shares in the last quarter. Northern Trust Corp grew its stake in shares of Monsanto by 0.7% during the 2nd quarter. Northern Trust Corp now owns 7,092,929 shares of the basic materials company’s stock worth $839,519,000 after acquiring an additional 47,725 shares in the last quarter. Finally, Flossbach Von Storch AG grew its stake in shares of Monsanto by 7.5% in the second quarter. Flossbach Von Storch AG now owns 4,397,000 shares of the basic materials company’s stock valued at $520,429,000 after buying an additional 307,600 shares in the last quarter. 74.98% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: “Assetmark Inc. Raises Stake in Monsanto Company (MON)” was first published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/11/23/assetmark-inc-raises-stake-in-monsanto-company-mon.html.

Monsanto Company (NYSE:MON) traded down $0.26 on Thursday, hitting $118.22. The stock had a trading volume of 1,847,100 shares, compared to its average volume of 1,941,602. Monsanto Company has a 12 month low of $100.87 and a 12 month high of $122.79. The company has a quick ratio of 0.83, a current ratio of 1.35 and a debt-to-equity ratio of 1.12. The firm has a market capitalization of $51,930.00, a P/E ratio of 21.42, a P/E/G ratio of 1.70 and a beta of 1.05.

Monsanto (NYSE:MON) last posted its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The company had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.51 billion. During the same quarter last year, the firm earned $0.07 earnings per share. The company’s revenue was up 4.8% on a year-over-year basis. sell-side analysts expect that Monsanto Company will post 5.74 EPS for the current year.

Several research firms recently weighed in on MON. UBS Group AG cut shares of Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 target price for the company. in a research note on Friday, August 18th. Royal Bank Of Canada reissued a “hold” rating and issued a $128.00 target price on shares of Monsanto in a research note on Wednesday, November 15th. Zacks Investment Research cut shares of Monsanto from a “buy” rating to a “hold” rating in a research note on Wednesday, August 30th. Piper Jaffray Companies set a $128.00 target price on shares of Monsanto and gave the company a “buy” rating in a research note on Friday, August 11th. Finally, Wells Fargo & Company raised their target price on shares of Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a research note on Tuesday, October 10th. Eleven analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $124.61.

In related news, COO Brett D. Begemann sold 22,640 shares of the business’s stock in a transaction dated Monday, September 25th. The stock was sold at an average price of $120.03, for a total value of $2,717,479.20. Following the completion of the transaction, the chief operating officer now owns 85,439 shares of the company’s stock, valued at $10,255,243.17. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO Pierre Courduroux sold 4,320 shares of the business’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $122.00, for a total value of $527,040.00. Following the completion of the transaction, the chief financial officer now directly owns 48,388 shares of the company’s stock, valued at approximately $5,903,336. The disclosure for this sale can be found here. Insiders have sold 49,236 shares of company stock valued at $5,931,934 in the last three months. Insiders own 0.79% of the company’s stock.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.